 |
|
University of Georgia researchers discover cell-wall carbohydrate that is crucial to anthrax bacterium
October 02, 2006Athens, Ga. - A week after the 9/11 attacks in 2001, the letters began to arrive. Someone filled envelopes with a deadly strain of anthrax bacteria and mailed them to two U.S. senators and several offices of the news media. Five people died, and 17 others became infected.
Since that time, governmental authorities have been engaged in a race to find ways to keep citizens safe if terrorists attack again with Bacillus anthracis, the bacterium that causes anthrax. Now, researchers at the University of Georgia, collaborating with scientists at the federal Centers for Disease Control and Prevention (CDC) in Atlanta, have discovered the structure of a unique cell-wall carbohydrate in B. anthracis.
The unique nature of the carbohydrate makes the molecule an important target for evaluating its role in virulence and survival of the anthrax bacterium, the development of new diagnostic tests and perhaps even as a new vaccine additive.
Russell Carlson of the department of biochemistry and molecular biology at the University of Georgia and faculty member at UGA's Complex Carbohydrate Research Center (CCRC), was corresponding author on a paper reporting the research, which was just published in the online version of the Journal of Biological Chemistry. Other authors from the CCRC include Biswa Choudhury, Christine Leoff, Elke Saile and Elmar Kannenberg. Collaborators at CDC were Patricia Wilkins and Conrad P. Quinn.
Anthrax is a naturally occurring animal disease. This year alone there have been several large outbreaks in animals in the U.S. and Canada, so understanding the structure of important parts of B. anthracis has a wide variety of potential applications. The new UGA research is not directly about vaccine development, and much more research needs to be done before the full potential of this unique anthrax molecule is understood.
The problems facing researchers as they unravel all the molecular riddles of anthrax are enormous. There are more than 100 known strains of B. anthracis, and one of the most virulent is called the Ames Strain. It is this strain that was mailed to victims in the fall of 2001.
Effective vaccines and antibiotics against anthrax do exist. Indeed, the federal government began Project BioShield, a $5.6 billion initiative, even before the last anthrax letter was delivered in 2001. Still, a New York Times story on September 18 reported that despite a $900 million "push to add a new anthrax vaccine to the stockpile," there have been setbacks. The Times reported that "only a small fraction of the anticipated remedies are available."
As a first step in understanding the structure and function of cell wall carbohydrates, the research team examined four Bacillus anthracis strains - Ames, Pasteur, Sterne and UT60 - and compared them to two related strains of Bacillus cereus, a soil-dwelling bacterium that causes food-borne illnesses. Cultures of these strains and the initial cell wall preparations were prepared by CDC researchers in their biosafety labs.
One important discovery in the just-reported research is that the newly discovered carbohydrate in the cell wall of B. anthracis is "species specific"; that is, of the strains tested, it was only found in the anthrax bacterium. This is one of several necessary conditions for a molecule that may be used to prepare rapid diagnostic tests for anthrax.
The research was supported by grants from the National Institutes of Health (to Carlson) and the U.S. Department of Energy (to the CCRC).
University of Georgia
Russell Carlson of the department of biochemistry and molecular biology at the University of Georgia and faculty member at UGA's Complex Carbohydrate Research Center (CCRC), was corresponding author on a paper reporting the research, which was just published in the online version of the Journal of Biological Chemistry. Other authors from the CCRC include Biswa Choudhury, Christine Leoff, Elke Saile and Elmar Kannenberg. Collaborators at CDC were Patricia Wilkins and Conrad P. Quinn.
Anthrax is a naturally occurring animal disease. This year alone there have been several large outbreaks in animals in the U.S. and Canada, so understanding the structure of important parts of B. anthracis has a wide variety of potential applications. The new UGA research is not directly about vaccine development, and much more research needs to be done before the full potential of this unique anthrax molecule is understood.
The problems facing researchers as they unravel all the molecular riddles of anthrax are enormous. There are more than 100 known strains of B. anthracis, and one of the most virulent is called the Ames Strain. It is this strain that was mailed to victims in the fall of 2001.
Effective vaccines and antibiotics against anthrax do exist. Indeed, the federal government began Project BioShield, a $5.6 billion initiative, even before the last anthrax letter was delivered in 2001. Still, a New York Times story on September 18 reported that despite a $900 million "push to add a new anthrax vaccine to the stockpile," there have been setbacks. The Times reported that "only a small fraction of the anticipated remedies are available."
As a first step in understanding the structure and function of cell wall carbohydrates, the research team examined four Bacillus anthracis strains - Ames, Pasteur, Sterne and UT60 - and compared them to two related strains of Bacillus cereus, a soil-dwelling bacterium that causes food-borne illnesses. Cultures of these strains and the initial cell wall preparations were prepared by CDC researchers in their biosafety labs.
One important discovery in the just-reported research is that the newly discovered carbohydrate in the cell wall of B. anthracis is "species specific"; that is, of the strains tested, it was only found in the anthrax bacterium. This is one of several necessary conditions for a molecule that may be used to prepare rapid diagnostic tests for anthrax.
The research was supported by grants from the National Institutes of Health (to Carlson) and the U.S. Department of Energy (to the CCRC).
University of Georgia
Anthrax Current Events and Anthrax News RSSBetter immune defense against anthrax
Scientists discover a gene in anthrax-causing bacteria may help defend against this form of bio-warfare.
Argonne researchers develop method that aims to stabilize antibodies
Researchers at the U.S. Department of Energy's Argonne National Laboratory have developed a systematic method to improve the stability of antibodies.
Early detection and quick response are key to defense against anthrax attack
A large attack on a major metropolitan area with airborne anthrax could affect more than a million people, necessitating their treatment with powerful antibiotics.
Data published in the New England Journal of Medicine support use of raxibacumab (ABthrax) for the treatment of inhalation anthrax
Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced publication by the New England Journal of Medicine of the results of two pivotal animal efficacy studies, which showed the life-saving potential of the Company's human monoclonal antibody drug raxibacumab.
One secret to how TB sticks with you
Mycobacterium tuberculosis is arguably the world's most successful infectious agent because it knows how to avoid elimination by slowing its own growth to a crawl.
Unexpected discovery can open a new chapter in the fight against tuberculosis
A close relative of the microorganism that causes tuberculosis in humans has been found to form spores.
Genetic switch potential key to new class of antibiotics
Researchers have determined the structure of a key genetic mechanism at work in bacteria, including some that are deadly to humans, in an important step toward the design of a new class of antibiotics.
UI chemists' DNA biosynthesis discovery could lead to better antibiotics
Combating several human pathogens, including some biological warfare agents, may one day become a bit easier thanks to research reported by a University of Iowa chemist and his colleagues in the April 16 issue of the journal Nature.
Scientists discover new chemical reaction for DNA production in bacteria and viruses
A team of researchers has discovered a new chemical reaction for producing one of the four nucleotides, or building blocks, needed to build DNA.
OHSU scientists partner with others to form center aimed at combating infectious diseases
Oregon Health & Science University and the University of Washington, along with a number of partner institutions across the Northwest, have received federal funding to form a regional research center aimed at combating emerging or re-emerging infectious diseases that pose a serious threat to human health.
More Anthrax Current Events and Anthrax News Articles
 |
Among the Living by Anthrax If Metallica and Slayer invented speed metal, Anthrax brought it to the East Coast and imbued it with the attitude and excitement of New York hardcore. Among the Living is, without a doubt, their finest hour--a roaring, adrenaline-pumped collection of flailing beats, precise, razor-edged riffs and shout-along refrains. Unlike most full-throttle metal vocalists of the era, Joey Belladonna chose to sing as well as shout, giving songs like "Among the Living," "Indians" and "Efilnikcufecin" ("nice fuckin' life" spelled backwards) a decided melodic edge. Yet Scott Ian and Dan Spitz's buzzsaw guitar flurries, and Charlie Benante's insistent drumming, prevented the songs from ever degenerating into the run-of-the-mill heavy metal they so despised. --Jon Wiederhorn |
 |
Spreading the Disease by Anthrax |
![Among The Living [Explicit]](http://ecx.images-amazon.com/images/I/51ZprdREUQL._SL160_.jpg) |
Among The Living [Explicit] Anthrax (Primary Contributor) |
 |
Among the Living by Anthrax Pioneering metal band Anthrax, one of the genre's most influential, innovative and respected groups, melded the speed and fury of hardcore punk with the guitars and vocals of heavy metal to help create speed and thrash metal. Now what many consider the group's greatest album, 1987's "Among The Living," has been expanded with bonus tracks and a concert DVD, and digitally remastered for the first time, for the CD+DVD package AMONG THE LIVING (DELUXE EDITION) "Among The Living," originally produced by Eddie Kramer and Anthrax, was the band's third full-length album and featured the lineup of singer Joe Belladonna, lead guitarist Dan Spitz, rhythm guitarist Scott Ian, bassist Frank Bello and drummer Charlie Benante. Building on an underground following with signature tracks such as "I... |
 |
Persistence of Time by Anthrax |
|
Bring The Noise Anthrax (Primary Contributor) | |
 |
State of Euphoria by Anthrax |
 |
Anthrax: Anthrology: No Hit Wonders 1985-1991 by Anthrax |
 |
Sound of White Noise - Expanded Edition Anthrax (Primary Contributor) |
 |
We've Come for You All by Anthrax You'll find no rap metal or nu metal on We've Come for You All--just Anthrax's inimitable thrash-metal melded with contemporary melodies, dynamics, and booming, arena-worthy production. Two way-cool guests--Roger Daltrey and Pantera guitarist Dimebag Darrell--are under-utilized on their respective songs, but with machine-gun, heart-pounding double-bass drums and vocalist John Bush's convincing snarl, it hardly matters. Bush, who has been in Anthrax since the early '90s, has been part of much of the group's best and most mature (if not most commercially successful) material. The dynamic "Superhero" is a winner, as is the radio-ready, not-too-heavy "Safe Home." "Nobody Knows Anything" and "Strap It On" are the best of the heaviest entries. Effective acoustic moments, Scott Ian's guitar... |
| © 2009 BrightSurf.com |